No Data
No Data
Lexaria Bioscience Hires Contract Research Organization For 12-week Study
Lexaria Bioscience (LEXX) said Tuesday that it hired a contract research organization to manage its 12-week chronic study, GLP-1-H24-4, to evaluate different DehydraTECH-GLP-1 formulations and other t
Express News | Lexaria Bioscience Hires CRO To Oversee 12-Week Study On DehydraTECH-GLP-1 Formulations; Major Objectives Include Weight Loss And Blood Sugar Reduction
Express News | Lexaria Bioscience: Awards Cro Contract for 12-Week Dehydratech GLP-1 Chronic Human Study
Express News | Lexaria Bioscience Announces Progress In Human Pilot Study GLP-1-H24-2; Second Round Of Dosing Completed For All Nine Participants, Final Arm Expected To Finish By Early July
Express News | Lexaria Bioscience Corp: Expects to Complete Third (Final) Arm of Study in Early July
Express News | Lexaria Bioscience Corp: Dosing Continues in Lexaria's Second GLP-1 Human Pilot Study
No Data
Stock_Drift : Duly noted
PYUN970IHaveChosen : TTSAB! (lol) not sure where the previous post came from! Not here….
TrytosaveabitOP PYUN970IHaveChosen: You’re welcome